Use of Skin Testing Screening and Desensitization Before the First Exposure of Rituximab

Abstract

Objective

This study aimed to evaluate the incidence and severity of immediate hypersensitivity reactions (HSRs) in the first exposure to rituximab with the adoption of skin testing screening and desensitization and investigate the value of skin testing as a predictive tool for immediate HSR to rituximab.

Methods

This was a prospective intervention study. Patients with hematological malignancies who required rituximab were recruited. Skin testing screening with rituximab was conducted before the first infusion. Patients with positive skin testing results underwent desensitization, while those with negative results received rituximab at a standard infusion rate. All immediate HSRs were recorded, and the predictive value of positive skin testing results for immediate HSRs to rituximab was analyzed.

Results

In the 19 patients who adopted the novel protocol, six patients (31.6%) had immediate HSRs during the first infusion, with three mild reactions (15.8%), two moderate reactions (10.5%), and only one severe reaction (5.3%). The positive predictive value of intradermal test (IDT) with 1 mg/mL rituximab solution for immediate HSR was 100%, and the negative predictive value was 84.6%.

Conclusion

The protocol of skin testing screening and desensitization might have some potential to control the incidence and severity of immediate HSRs to rituximab during the first exposure. IDT result before the first infusion could become a useful predictor for immediate HSR to rituximab.

Keywords:

• rituximab
• hypersensitivity
• skin testing
• predictive value of tests
• desensitization
• lymphoma

Abbreviations

AUC, Area under the curve; HSRs, Hypersensitivity reactions; IDT, Intradermal test; IgE, Immunoglobulin E; IPI, International prognostic index; mAbs, Monoclonal antibodies; NMBA, Neuromuscular-blocking agents; PEG, Polyethylene glycol; ROC, Receiver operating characteristic; SPT, Skin prick tests.

Data Sharing Statement

All the data of this study have been included in this manuscript.

Disclosure

The authors declare that there is no conflict of interest.